Clinical Trials

NCT05886049 | RECRUITING | PHASE1
28 participants

Testing the Addition of an Anti-cancer Drug, SNDX-5613, to the Standard Chemotherapy Treatment (Daunorubicin and Cytarabine) for Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes in NPM1 or MLL/KMT2A Gene

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2024-06-20
Completion:
2027-12-31
Conditions
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05848011 | COMPLETED | PHASE2
154 participants

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2023-09-28
Completion:
2026-02-19
Conditions
  • Androgen-Independent Prostatic Cancer
  • Androgen-Independent Prostatic Neoplasms
  • Prostate Cancer Recurrent
  • Androgen-Insensitive Prostatic Cance
  • Androgen-Resistant Prostatic Cancer
  • Hormone Refractory Prostatic Cancer
  • Immunotherapy
  • Immune Checkpoint Inhibitor
  • Inhibitory Checkpoint Molecule
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page